EV/EBITDA
-6.81
-0.37-5.75%
Thu, 02 Jan 2025 21:01:29 GMT
Summary:
Spyre Therapeutics EV/EBITDA is currently -6.81, with a fall of -0.37 (-5.75%) during the most recent trading day. Over the past year, it has dropped by -2.24 (-49.02%). SYRE EV/EBITDA is now -355.06% below its all-time high of 2.67.SYRE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -5.8% |
| 1 m1 month | +13.9% |
| 3 m3 months | +1.7% |
| 6 m6 months | -1.0% |
| ytdytd | -5.8% |
| 1 y1 year | -49.0% |
| 5 y5 years | -157.9% |
SYRE EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -6.42 | -6.1% | -8.18 | +16.8% |
| 3 m | 3 months | -6.42 | -6.1% | -10.47 | +35.0% |
| 6 m | 6 months | -2.74 | -148.5% | -10.47 | +35.0% |
| 1 y | 1 year | -2.74 | -148.5% | -11.80 | +42.3% |
| 3 y | 3 years | 2.67 | -355.1% | -11.80 | +42.3% |
| 5 y | 5 years | 2.67 | -355.1% | -11.80 | +42.3% |
| alltime | all time | 2.67 | -355.1% | -11.80 | +42.3% |
Spyre Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.81(+5.7%) |
| 2024 | -6.44(+40.0%) |
| 2023 | -4.60(<-9900.0%) |
| 2022 | 0.01(-100.3%) |
| 2021 | -3.50(-3.8%) |
| Date | Value |
|---|---|
| 2020 | -3.64(+40.0%) |
| 2019 | -2.60(-25.9%) |
| 2018 | -3.51(+24.5%) |
| 2017 | -2.82(+475.5%) |
| 2016 | -0.49 |
FAQ
- What is Spyre Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Spyre Therapeutics?
- What is SYRE EV/EBITDA year-to-date change?
- What is Spyre Therapeutics EV/EBITDA year-on-year change?
What is Spyre Therapeutics EV/EBITDA?
The current EV/EBITDA of SYRE is -6.81
What is the all time high EV/EBITDA for Spyre Therapeutics?
Spyre Therapeutics all-time high EV/EBITDA is 2.67
What is SYRE EV/EBITDA year-to-date change?
Spyre Therapeutics EV/EBITDA has changed by -0.37 (-5.75%) since the beginning of the year
What is Spyre Therapeutics EV/EBITDA year-on-year change?
Over the past year, SYRE EV/EBITDA has changed by -2.24 (-49.02%)